China Isotope & Radiation Corporation

Equities

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
10.1 HKD -9.82% Intraday chart for China Isotope & Radiation Corporation -15.27% -24.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
China Isotope & Radiation Corporation Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable on 06 August 2024 CI
China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Isotope & Radiation Corporation Announces Resignation of Chen Shoulei as Non-Executive Director, Vice Chairman, Members of the Strategy Committee, the Audit and Risk Management Committee and the Legal Affairs Committee of the Board CI
China Isotope & Radiation Breath Test Kit Gets a Clinical Approval Nod MT
China Isotope & Radiation Corporation Announces Approval by the National Medical Products Administration, Shenzhen Zhonghe Headway Bio-Sci & Tech Co. Ltd CI
China Isotope & Radiation Arm Secures Safety License for Production Facility in Xinjiang MT
China Isotope & Radiation Subsidiary Secures Compliance Accreditation MT
CIRC to Buy Radiation Processing Research and Technology Firm MT
China Isotope & Radiation Gets New Direct Controlling Shareholder MT
China Isotope & Radiation Corporation Elects Zhang Junqi as an Executive Director CI
China Isotope & Radiation Corporation Announces Resignation of Wang Suohui as Director CI
China Isotope's Nuclear Energy Project Gets 'Outstanding' Rating MT
CIRC Wins ESG Case Award in China MT
CIRC Boosts Capital Injection in Financial Company MT
China Isotope & Radiation Corporation Announces Executive Changes CI
China Isotope & Radiation Corporation Appoints Mr. Fan Guomin Employee Representative Director CI
CIRC Renews Multiple Agreements with Controlling Shareholder, Affiliates for Two Years MT
China Isotope & Radiation Corporation Enter into the Renewed Supply Agreement with China National Nuclear Corporation CI
China Isotope & Radiation Corporation Enter into the Renewed Consulting Services FeeFramework Agreement with CNNC Tongxing Nuclear Technology Co., Ltd CI
China Isotope & Radiation Corporation Enter into the Renewed Carbon-14 Supply Agreement with Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd CI
China Isotope & Radiation to Sell In Vitro Diagnostic Reagents Firm MT
CNNC Accuray's Tumor Imaging Device Obtains Registration, Manufacturing License in China MT
China Isotope & Radiation Reveals Fuzhi Intelligent Nuclear Medicine System at Medical Conference MT
China Isotope & Radiation Corporation Unveils Fuzhi Intelligent Nuclear Medicine System at the 2023 Annual Academic Conference of Chinese Society of Nuclear Medicine CI
China Isotope & Radiation Parent CNNC Plans Gratuitous Transfer of Shares MT
Chart China Isotope & Radiation Corporation
More charts
China Isotope & Radiation Corporation is a China-based company mainly engaged in research, development, manufacturing and sales of radiopharmaceuticals and radioactive source products. The Company operates mainly through five segments. The Pharmaceuticals segment is mainly engaged in the manufacture and sales of various radiopharmaceuticals for imaging diagnosis and treatment, urea breath test kits and testers, as well as in vitro diagnostic reagents and kits. The Radioactive Source Product segment is mainly engaged in the production and sales of various radioactive source products, and provides related technical services. The Irradiation segment mainly provides irradiation sterilization services and others. The Radiotherapy Equipment and Related Services segment is mainly engaged in the research and development of radiotherapy equipment. The Independent Medical Laboratory Services and Other Business segment mainly provides independent medical laboratory services.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock China Isotope & Radiation Corporation - Hong Kong S.E.
  4. News China Isotope & Radiation Corporation
  5. China Isotope & Radiation Arm Delivers Lutetium Chloride Solution for R&D in China; Shares Rise 3%